Nucleostemin siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational EvidenceCancersMarch 25, 2021Megiorni F, Camero S, Pontecorvi P, Camicia L, Marampon F, Ceccarelli S, Anastasiadou E, Bernabò N, Perniola G, Pizzuti A, et al.interfering RNAs (siRNAs) against human BRD4 (si-BRD4, sc-43639 by Santa Cruz Biotechnology), GNL3 (si-GNL3, sc-45830 by Santa Cruz Biotechnology), or siRNA negative control (si-NC, sc-37007 by Santa Cruz Biotechnology)

(2) BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cellsCancer lettersJune 1, 2020Camero S, Camicia L, Marampon F, Ceccarelli S, Shukla R, Mannarino O, Pizer B, Schiavetti A, Pizzuti A, Tombolini V, et al.

Nucleostemin siRNA (h)